Hydroxychloroquine in Mild Graves' Orbitopathy

NCT05126147 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Graves Ophthalmopathy

Interventions

DRUG: Hydroxychloroquine

Sponsor

National Taiwan University Hospital